Literature DB >> 26147065

GABAA receptor deficits predict recovery in patients with disorders of consciousness: A preliminary multimodal [(11) C]Flumazenil PET and fMRI study.

Pengmin Qin1,2,3, Xuehai Wu4, Niall W Duncan1,2,3,5, Weiqi Bao6, Weijun Tang7, Zhengwei Zhang6, Jin Hu4, Yi Jin4, Xing Wu4, Liang Gao4, Lu Lu8, Yihui Guan6, Timothy Lane2,3, Zirui Huang2, Yelena G Bodien9, Joseph T Giacino9, Ying Mao4, Georg Northoff1,2,3,5,10.   

Abstract

OBJECTIVES: Disorders of consciousness (DoC)-that is, unresponsive wakefulness syndrome/vegetative state and minimally conscious state-are debilitating conditions for which no reliable markers of consciousness recovery have yet been identified. Evidence points to the GABAergic system being altered in DoC, making it a potential target as such a marker. EXPERIMENTAL
DESIGN: In our preliminary study, we used [(11) C]Flumazenil positron emission tomography to establish global GABAA receptor binding potential values and the local-to-global (LTG) ratio of these for specific regions. These values were then compared between DoC patients and healthy controls. In addition, they were correlated with behavioral improvements for the patients between the time of scanning and 3 months later. Functional magnetic resonance imaging resting-state functional connectivity was also calculated and the same comparisons made. PRINCIPAL OBSERVATIONS: lobal GABAA receptor binding was reduced in DoC, as was the LTG ratio in specifically the supragenual anterior cingulate. Both of these measures correlated with behavioral improvement after 3 months. In contrast to these measures of GABAA receptor binding, functional connectivity did not correlate with behavioral improvement.
CONCLUSIONS: Our preliminary findings point toward GABAA receptor binding being a marker of consciousness recovery in DoC.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  Zolpidem; default-mode network; executive-control network; functional connectivity; minimally conscious state; salience network; unresponsive wakefulness syndrome; vegetative state

Mesh:

Substances:

Year:  2015        PMID: 26147065      PMCID: PMC6869690          DOI: 10.1002/hbm.22883

Source DB:  PubMed          Journal:  Hum Brain Mapp        ISSN: 1065-9471            Impact factor:   5.038


  45 in total

1.  PET scanning and neuronal loss in acute vegetative state.

Authors:  S Laureys; M E Faymonville; G Moonen; A Luxen; P Maquet
Journal:  Lancet       Date:  2000-05-20       Impact factor: 79.321

2.  Anterior cingulate activity and the self in disorders of consciousness.

Authors:  Pengmin Qin; Haibo Di; Yijun Liu; Senming Yu; Qiyong Gong; Niall Duncan; Xuchu Weng; Steven Laureys; Georg Northoff
Journal:  Hum Brain Mapp       Date:  2010-03-24       Impact factor: 5.038

3.  Drug induced arousal from the permanent vegetative state.

Authors:  Ralf Clauss; Wally Nel
Journal:  NeuroRehabilitation       Date:  2006       Impact factor: 2.138

4.  The self and its resting state in consciousness: an investigation of the vegetative state.

Authors:  Zirui Huang; Rui Dai; Xuehai Wu; Zhi Yang; Dongqiang Liu; Jin Hu; Liang Gao; Weijun Tang; Ying Mao; Yi Jin; Xing Wu; Bin Liu; Yao Zhang; Lu Lu; Steven Laureys; Xuchu Weng; Georg Northoff
Journal:  Hum Brain Mapp       Date:  2013-07-01       Impact factor: 5.038

5.  Selective neuronal damage and borderzone infarction in carotid artery occlusive disease: a 11C-flumazenil PET study.

Authors:  Hiroshi Yamauchi; Takashi Kudoh; Yoshihiko Kishibe; Jinei Iwasaki; Shinya Kagawa
Journal:  J Nucl Med       Date:  2005-12       Impact factor: 10.057

Review 6.  PET in coma and in vegetative state.

Authors:  W-D Heiss
Journal:  Eur J Neurol       Date:  2011-07-28       Impact factor: 6.089

Review 7.  Coma and consciousness: paradigms (re)framed by neuroimaging.

Authors:  Steven Laureys; Nicholas D Schiff
Journal:  Neuroimage       Date:  2011-12-27       Impact factor: 6.556

Review 8.  Neurotransmitters in disorders of consciousness and brain damage.

Authors:  R P Clauss
Journal:  Med Hypotheses       Date:  2011-05-05       Impact factor: 1.538

9.  Measurement of GABAA receptor binding in vivo with [11C]flumazenil: a test-retest study in healthy subjects.

Authors:  Elina Salmi; Sargo Aalto; Jussi Hirvonen; Jaakko W Långsjö; Anu T Maksimow; Vesa Oikonen; Liisa Metsähonkala; Jussi Virkkala; Kjell Någren; Harry Scheinin
Journal:  Neuroimage       Date:  2008-03-04       Impact factor: 6.556

10.  REST: a toolkit for resting-state functional magnetic resonance imaging data processing.

Authors:  Xiao-Wei Song; Zhang-Ye Dong; Xiang-Yu Long; Su-Fang Li; Xi-Nian Zuo; Chao-Zhe Zhu; Yong He; Chao-Gan Yan; Yu-Feng Zang
Journal:  PLoS One       Date:  2011-09-20       Impact factor: 3.240

View more
  5 in total

Review 1.  Clinical Decision on Disorders of Consciousness After Acquired Brain Injury: Stepping Forward.

Authors:  Rui-Zhe Zheng; Zeng-Xin Qi; Zhe Wang; Ze-Yu Xu; Xue-Hai Wu; Ying Mao
Journal:  Neurosci Bull       Date:  2022-07-08       Impact factor: 5.203

2.  Posterior cingulate cross-hemispheric functional connectivity predicts the level of consciousness in traumatic brain injury.

Authors:  Haosu Zhang; Rui Dai; Pengmin Qin; Weijun Tang; Jin Hu; Xuchu Weng; Xing Wu; Ying Mao; Xuehai Wu; Georg Northoff
Journal:  Sci Rep       Date:  2017-03-24       Impact factor: 4.379

3.  Prognosis for patients with cognitive motor dissociation identified by brain-computer interface.

Authors:  Jiahui Pan; Qiuyou Xie; Pengmin Qin; Yan Chen; Yanbin He; Haiyun Huang; Fei Wang; Xiaoxiao Ni; Andrzej Cichocki; Ronghao Yu; Yuanqing Li
Journal:  Brain       Date:  2020-04-01       Impact factor: 13.501

4.  The Role of Neuroimaging Techniques in Establishing Diagnosis, Prognosis and Therapy in Disorders of Consciousness.

Authors:  Olivia Gosseries; Francesca Pistoia; Vanessa Charland-Verville; Antonio Carolei; Simona Sacco; Steven Laureys
Journal:  Open Neuroimag J       Date:  2016-05-13

5.  A Systematic Review and Meta-Analysis of the Relationship Between Brain Data and the Outcome in Disorders of Consciousness.

Authors:  Boris Kotchoubey; Yuri G Pavlov
Journal:  Front Neurol       Date:  2018-05-08       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.